Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash-to-Debt 4.12
ELMD's Cash-to-Debt is ranked higher than
58% of the 288 Companies
in the Global Medical Devices industry.

( Industry Median: 2.45 vs. ELMD: 4.12 )
Ranked among companies with meaningful Cash-to-Debt only.
ELMD' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.1  Med: 1.16 Max: N/A
Current: 4.12
Equity-to-Asset 0.83
ELMD's Equity-to-Asset is ranked higher than
86% of the 265 Companies
in the Global Medical Devices industry.

( Industry Median: 0.62 vs. ELMD: 0.83 )
Ranked among companies with meaningful Equity-to-Asset only.
ELMD' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.52  Med: 0.77 Max: 0.85
Current: 0.83
0.52
0.85
Interest Coverage 33.72
ELMD's Interest Coverage is ranked lower than
61% of the 226 Companies
in the Global Medical Devices industry.

( Industry Median: 93.54 vs. ELMD: 33.72 )
Ranked among companies with meaningful Interest Coverage only.
ELMD' s Interest Coverage Range Over the Past 10 Years
Min: 0.67  Med: 8.8 Max: 46.4
Current: 33.72
0.67
46.4
Piotroski F-Score: 5
Altman Z-Score: 9.39
Beneish M-Score: -2.30
WACC vs ROIC
2.95%
11.48%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating Margin % 9.70
ELMD's Operating Margin % is ranked higher than
71% of the 270 Companies
in the Global Medical Devices industry.

( Industry Median: 2.62 vs. ELMD: 9.70 )
Ranked among companies with meaningful Operating Margin % only.
ELMD' s Operating Margin % Range Over the Past 10 Years
Min: -12.1  Med: 6.75 Max: 18.89
Current: 9.7
-12.1
18.89
Net Margin % 6.09
ELMD's Net Margin % is ranked higher than
66% of the 270 Companies
in the Global Medical Devices industry.

( Industry Median: 1.50 vs. ELMD: 6.09 )
Ranked among companies with meaningful Net Margin % only.
ELMD' s Net Margin % Range Over the Past 10 Years
Min: -8.8  Med: 5.56 Max: 10.25
Current: 6.09
-8.8
10.25
ROE % 8.81
ELMD's ROE % is ranked higher than
68% of the 263 Companies
in the Global Medical Devices industry.

( Industry Median: 2.08 vs. ELMD: 8.81 )
Ranked among companies with meaningful ROE % only.
ELMD' s ROE % Range Over the Past 10 Years
Min: -9.67  Med: 8.2 Max: 26.43
Current: 8.81
-9.67
26.43
ROA % 7.19
ELMD's ROA % is ranked higher than
78% of the 291 Companies
in the Global Medical Devices industry.

( Industry Median: 0.20 vs. ELMD: 7.19 )
Ranked among companies with meaningful ROA % only.
ELMD' s ROA % Range Over the Past 10 Years
Min: -7.73  Med: 6.03 Max: 12.78
Current: 7.19
-7.73
12.78
ROC (Joel Greenblatt) % 19.96
ELMD's ROC (Joel Greenblatt) % is ranked higher than
69% of the 288 Companies
in the Global Medical Devices industry.

( Industry Median: 4.02 vs. ELMD: 19.96 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
ELMD' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -12.43  Med: 12.09 Max: 34.71
Current: 19.96
-12.43
34.71
3-Year Revenue Growth Rate 14.40
ELMD's 3-Year Revenue Growth Rate is ranked higher than
80% of the 227 Companies
in the Global Medical Devices industry.

( Industry Median: 4.60 vs. ELMD: 14.40 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
ELMD' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -7.7  Med: 1.65 Max: 21.4
Current: 14.4
-7.7
21.4
GuruFocus has detected 1 Warning Sign with Electromed Inc $ELMD.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» ELMD's 10-Y Financials

Financials (Next Earnings Date: 2017-05-07 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

ELMD Guru Trades in Q1 2016

Jim Simons 96,600 sh (New)
» More
Q2 2016

ELMD Guru Trades in Q2 2016

Jim Simons Sold Out
» More
Q3 2016

ELMD Guru Trades in Q3 2016

Jim Simons 83,200 sh (New)
» More
Q4 2016

ELMD Guru Trades in Q4 2016

Jim Simons 16,400 sh (-80.29%)
» More
» Details

Insider Trades

Latest Guru Trades with ELMD

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 334510    SIC: 3845
Compare:NAS:ETRM, OTCPK:TITXF, OTCPK:BTCY, NAS:MGCD, OTCPK:BLOZF, OTCPK:RMSL, OTCPK:QTVLF, NAS:AVGR, OTCPK:VICA, OTCPK:BSGM, NAS:RWLK, OTCPK:DIZTF, OTCPK:LCTC, NAS:KOOL, NAS:MDVX, OTCPK:AVMXF, NAS:VIVE, OTCPK:ZMSPF, NAS:SPAN, OTCPK:MRIC » details
Electromed Inc develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products.

Electromed Inc was incorporated on 1992 in Minnesota corporation. The Company is engaged in the business of providing airway clearance products applying High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The Company markets its products in the United States to the home health care and institutional markets for use by patients in personal residences, hospitals and clinics. The Company also sells internationally both directly and through distributors. It manufacture, market and sell products that provide HFCWO, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function. Its products are sold for both the home health care market and the institutional market for use by patients in hospitals. Additionally, it offers its products to a patient population that includes neuromuscular disorders such as cerebral palsy, muscular dystrophies, and ALS, the combination of emphysema and chronic bronchitis commonly known as chronic obstructive pulmonary disease, and patients with post-surgical complications or who are ventilator dependent or have other conditions involving excess secretion and impaired mucus transport. The SmartVest System is a portable, programmable, and multi-positional airway clearance machine that generates HFCWO and has been cleared by the Food and Drug Administration to promote airway clearance and improve bronchial drainage. The SmartVest System features a programmable electro-mechanical pulse generator and a pneumatic therapy garment, which together provide safe, comfortable, and effective airway clearance therapy. Some of its competitors are: Respiratory Technologies Inc, The Vest and RespirTech's. It has received U.S. trademark and service mark registrations such as MEDPULSE, MEDPULSE RESPIRATORY VEST SYSTEM, SMARTVEST, SMARTVEST WRAP, SMARTWRAP, FACT, SOFT START, TRIMLINE, and CREATING SUPERIOR CARE THROUGH INNOVATION. Its medical devices are subject to regulation by numerous government agencies, including the FDA and comparable foreign agencies.

Ratios

vs
industry
vs
history
PE Ratio 29.12
ELMD's PE Ratio is ranked lower than
51% of the 178 Companies
in the Global Medical Devices industry.

( Industry Median: 27.89 vs. ELMD: 29.12 )
Ranked among companies with meaningful PE Ratio only.
ELMD' s PE Ratio Range Over the Past 10 Years
Min: 7.9  Med: 23.88 Max: 264
Current: 29.12
7.9
264
PE Ratio without NRI 29.12
ELMD's PE Ratio without NRI is ranked higher than
50% of the 179 Companies
in the Global Medical Devices industry.

( Industry Median: 28.39 vs. ELMD: 29.12 )
Ranked among companies with meaningful PE Ratio without NRI only.
ELMD' s PE Ratio without NRI Range Over the Past 10 Years
Min: 7.9  Med: 23.88 Max: 264
Current: 29.12
7.9
264
PB Ratio 2.38
ELMD's PB Ratio is ranked higher than
64% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 3.35 vs. ELMD: 2.38 )
Ranked among companies with meaningful PB Ratio only.
ELMD' s PB Ratio Range Over the Past 10 Years
Min: 0.57  Med: 1.38 Max: 2.85
Current: 2.38
0.57
2.85
PS Ratio 1.76
ELMD's PS Ratio is ranked higher than
69% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 3.31 vs. ELMD: 1.76 )
Ranked among companies with meaningful PS Ratio only.
ELMD' s PS Ratio Range Over the Past 10 Years
Min: 0.53  Med: 1.03 Max: 2.04
Current: 1.76
0.53
2.04
Price-to-Free-Cash-Flow 117.84
ELMD's Price-to-Free-Cash-Flow is ranked lower than
89% of the 109 Companies
in the Global Medical Devices industry.

( Industry Median: 29.73 vs. ELMD: 117.84 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
ELMD' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 5.05  Med: 12.5 Max: 336.88
Current: 117.84
5.05
336.88
Price-to-Operating-Cash-Flow 39.28
ELMD's Price-to-Operating-Cash-Flow is ranked lower than
81% of the 139 Companies
in the Global Medical Devices industry.

( Industry Median: 20.26 vs. ELMD: 39.28 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
ELMD' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 3.08  Med: 7.28 Max: 68.57
Current: 39.28
3.08
68.57
EV-to-EBIT 16.16
ELMD's EV-to-EBIT is ranked higher than
66% of the 162 Companies
in the Global Medical Devices industry.

( Industry Median: 23.96 vs. ELMD: 16.16 )
Ranked among companies with meaningful EV-to-EBIT only.
ELMD' s EV-to-EBIT Range Over the Past 10 Years
Min: -20.2  Med: 12.8 Max: 221.9
Current: 16.16
-20.2
221.9
EV-to-EBITDA 12.20
ELMD's EV-to-EBITDA is ranked higher than
67% of the 175 Companies
in the Global Medical Devices industry.

( Industry Median: 17.54 vs. ELMD: 12.20 )
Ranked among companies with meaningful EV-to-EBITDA only.
ELMD' s EV-to-EBITDA Range Over the Past 10 Years
Min: -465.6  Med: 9.5 Max: 25.9
Current: 12.2
-465.6
25.9
Current Ratio 6.83
ELMD's Current Ratio is ranked higher than
90% of the 284 Companies
in the Global Medical Devices industry.

( Industry Median: 2.33 vs. ELMD: 6.83 )
Ranked among companies with meaningful Current Ratio only.
ELMD' s Current Ratio Range Over the Past 10 Years
Min: 2.1  Med: 4.72 Max: 7.91
Current: 6.83
2.1
7.91
Quick Ratio 5.74
ELMD's Quick Ratio is ranked higher than
90% of the 284 Companies
in the Global Medical Devices industry.

( Industry Median: 1.67 vs. ELMD: 5.74 )
Ranked among companies with meaningful Quick Ratio only.
ELMD' s Quick Ratio Range Over the Past 10 Years
Min: 1.77  Med: 3.91 Max: 6.55
Current: 5.74
1.77
6.55
Days Inventory 171.28
ELMD's Days Inventory is ranked lower than
69% of the 254 Companies
in the Global Medical Devices industry.

( Industry Median: 125.58 vs. ELMD: 171.28 )
Ranked among companies with meaningful Days Inventory only.
ELMD' s Days Inventory Range Over the Past 10 Years
Min: 110.87  Med: 135.92 Max: 171.28
Current: 171.28
110.87
171.28
Days Sales Outstanding 127.89
ELMD's Days Sales Outstanding is ranked lower than
89% of the 240 Companies
in the Global Medical Devices industry.

( Industry Median: 66.89 vs. ELMD: 127.89 )
Ranked among companies with meaningful Days Sales Outstanding only.
ELMD' s Days Sales Outstanding Range Over the Past 10 Years
Min: 120.83  Med: 167.83 Max: 217.83
Current: 127.89
120.83
217.83
Days Payable 32.31
ELMD's Days Payable is ranked lower than
76% of the 227 Companies
in the Global Medical Devices industry.

( Industry Median: 57.49 vs. ELMD: 32.31 )
Ranked among companies with meaningful Days Payable only.
ELMD' s Days Payable Range Over the Past 10 Years
Min: 28.65  Med: 50.5 Max: 115.28
Current: 32.31
28.65
115.28

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -0.30
ELMD's 3-Year Average Share Buyback Ratio is ranked higher than
76% of the 209 Companies
in the Global Medical Devices industry.

( Industry Median: -3.40 vs. ELMD: -0.30 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
ELMD' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -10.4  Med: -4.1 Max: 0
Current: -0.3
-10.4
0

Valuation & Return

vs
industry
vs
history
Price-to-Net-Cash 31.06
ELMD's Price-to-Net-Cash is ranked lower than
75% of the 119 Companies
in the Global Medical Devices industry.

( Industry Median: 15.26 vs. ELMD: 31.06 )
Ranked among companies with meaningful Price-to-Net-Cash only.
ELMD' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 17.27  Med: 36.41 Max: 371
Current: 31.06
17.27
371
Price-to-Net-Current-Asset-Value 3.25
ELMD's Price-to-Net-Current-Asset-Value is ranked higher than
76% of the 217 Companies
in the Global Medical Devices industry.

( Industry Median: 6.50 vs. ELMD: 3.25 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
ELMD' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 1.02  Med: 2.27 Max: 3.33
Current: 3.25
1.02
3.33
Price-to-Tangible-Book 2.49
ELMD's Price-to-Tangible-Book is ranked higher than
69% of the 259 Companies
in the Global Medical Devices industry.

( Industry Median: 4.19 vs. ELMD: 2.49 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
ELMD' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.69  Med: 1.63 Max: 2.51
Current: 2.49
0.69
2.51
Price-to-Intrinsic-Value-Projected-FCF 2.49
ELMD's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
57% of the 127 Companies
in the Global Medical Devices industry.

( Industry Median: 2.23 vs. ELMD: 2.49 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
ELMD' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 1.16  Med: 2.08 Max: 2.85
Current: 2.49
1.16
2.85
Price-to-Median-PS-Value 1.71
ELMD's Price-to-Median-PS-Value is ranked lower than
81% of the 258 Companies
in the Global Medical Devices industry.

( Industry Median: 1.07 vs. ELMD: 1.71 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
ELMD' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.58  Med: 1.1 Max: 1.9
Current: 1.71
0.58
1.9
Price-to-Graham-Number 1.79
ELMD's Price-to-Graham-Number is ranked higher than
62% of the 131 Companies
in the Global Medical Devices industry.

( Industry Median: 2.42 vs. ELMD: 1.79 )
Ranked among companies with meaningful Price-to-Graham-Number only.
ELMD' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.66  Med: 1.49 Max: 4.51
Current: 1.79
0.66
4.51
Earnings Yield (Greenblatt) % 6.18
ELMD's Earnings Yield (Greenblatt) % is ranked higher than
85% of the 339 Companies
in the Global Medical Devices industry.

( Industry Median: -0.81 vs. ELMD: 6.18 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
ELMD' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 0.5  Med: 6.8 Max: 23.1
Current: 6.18
0.5
23.1

More Statistics

Revenue (TTM) (Mil) $23.65
EPS (TTM) $ 0.17
Beta0.04
Short Percentage of Float1.08%
52-Week Range $3.38 - 6.26
Shares Outstanding (Mil)8.23
» More Articles for ELMD

Headlines

Articles On GuruFocus.com
No related article found.

More From Other Websites
Electromed, Inc. :ELMD-US: Earnings Analysis: Q2, 2017 By the Numbers : March 17, 2017 Mar 17 2017
Titan Machinery Elects Two New Board Members Feb 28 2017
Electromed, Inc. to Distribute Aerobika® OPEP Device Feb 21 2017
Electromed, Inc.: Strong price momentum but will it sustain? Feb 14 2017
ELECTROMED, INC. Financials Feb 11 2017
ELECTROMED, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Feb 07 2017
Electromed, Inc. Announces Fiscal 2017 Second Quarter Financial Results Feb 07 2017
Q2 2017 Electromed Inc Earnings Release - After Market Close Feb 07 2017
Electromed, Inc. Announces Results of Cost-Effective Analysis of Using HFCWO in Patients with... Feb 01 2017
Electromed, Inc. Schedules Release of Second Quarter Fiscal 2017 Financial Results and Conference... Jan 25 2017
ELECTROMED, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a... Dec 16 2016
Electromed, Inc. to Participate in the Benchmark Micro Cap Discovery Conference on December 1, 2016 Nov 21 2016
ELECTROMED, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Nov 17 2016
ETFs with exposure to Electromed, Inc. : November 14, 2016 Nov 14 2016
Electromed, Inc. :ELMD-US: Earnings Analysis: Q1, 2017 By the Numbers : November 10, 2016 Nov 10 2016
ELECTROMED, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Nov 08 2016
Electromed, Inc. Announces Fiscal 2017 First Quarter Financial Results Nov 08 2016
Electromed, Inc. Introduces Expanded SmartVest® Garment and SmartVest SQL® Generator Colors to... Oct 26 2016
Electromed, Inc. Schedules Release of First Quarter Fiscal 2017 Financial Results and Conference... Oct 25 2016
Electromed, Inc.: Leads amongst peers with strong fundamentals Sep 09 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)